Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2020-01-01
|
| Col·lecció: | Case Reports in Anesthesiology |
| Accés en línia: | http://dx.doi.org/10.1155/2020/8767195 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|